| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | MYCBP2 OBSCN ARHGEF11 MADD CCDC88C ARHGEF7 SH3BP5L HERC2 PREX1 | 1.05e-04 | 231 | 160 | 9 | GO:0005085 |
| GeneOntologyMolecularFunction | endoplasmic reticulum-organelle membrane tether activity | 1.90e-04 | 3 | 160 | 2 | GO:0170009 | |
| GeneOntologyMolecularFunction | endoplasmic reticulum-autophagosome adaptor activity | 1.90e-04 | 3 | 160 | 2 | GO:0140506 | |
| GeneOntologyMolecularFunction | autophagosome-membrane adaptor activity | 1.90e-04 | 3 | 160 | 2 | GO:0160183 | |
| GeneOntologyMolecularFunction | oxoglutarate dehydrogenase (succinyl-transferring) activity | 3.79e-04 | 4 | 160 | 2 | GO:0004591 | |
| MousePheno | acoria | 2.71e-06 | 4 | 124 | 3 | MP:0012101 | |
| Domain | 2-oxogl_dehyd_N | 7.20e-05 | 2 | 159 | 2 | IPR032106 | |
| Domain | 2-oxogl_dehyd_N | 7.20e-05 | 2 | 159 | 2 | PF16078 | |
| Domain | 2oxoglutarate_DH_E1 | 2.15e-04 | 3 | 159 | 2 | IPR011603 | |
| Domain | KGD_C | 2.15e-04 | 3 | 159 | 2 | IPR031717 | |
| Domain | OxoGdeHyase_C | 2.15e-04 | 3 | 159 | 2 | PF16870 | |
| Domain | Homeobox_Pitx/unc30 | 2.15e-04 | 3 | 159 | 2 | IPR016233 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DGCR2 MYCBP2 SZT2 SPEG UBR4 NTSR1 OBSCN FBRSL1 CEP192 HUWE1 ARHGEF11 WNK1 ZDHHC8 CASZ1 MADD HIRA RABL6 CCDC88C FASN CELSR3 NUAK1 RRP12 PITX1 NAV2 LRP4 OGDHL ZFYVE26 SH3BP5L PLEC HERC2 SNAPC4 MBD5 CABIN1 ANKRD33B PREX1 TTC38 MYBL2 TJP3 | 4.65e-22 | 1105 | 165 | 38 | 35748872 |
| Pubmed | 5.64e-15 | 10 | 165 | 7 | 17984056 | ||
| Pubmed | The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. | 2.89e-13 | 8 | 165 | 6 | 17588759 | |
| Pubmed | 9.39e-12 | 12 | 165 | 6 | 10433963 | ||
| Pubmed | 1.74e-11 | 13 | 165 | 6 | 17668377 | ||
| Pubmed | 1.74e-11 | 13 | 165 | 6 | 7739628 | ||
| Pubmed | PRUNE2 RIPOR2 HUWE1 ARHGEF11 WNK1 MADD SYNJ2 ZFYVE26 HERC2 CABIN1 | 7.81e-11 | 104 | 165 | 10 | 9205841 | |
| Pubmed | Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. | 1.23e-10 | 17 | 165 | 6 | 11245978 | |
| Pubmed | CACNB4 LIMA1 PRR36 MYCBP2 PPFIA1 PPP1R9A UBR4 CNKSR2 ZNF318 HUWE1 ARHGEF11 HIRA CCDC88C FAM171A2 ARHGEF7 MTCL1 CDC73 HERC2 CABIN1 MGA UNC79 GOLGA3 LRRFIP2 | 2.17e-10 | 963 | 165 | 23 | 28671696 | |
| Pubmed | KDM5B MYCBP2 PPFIA1 UBR4 ZNF507 ZNF318 HUWE1 RB1CC1 TRIM24 KIAA1671 FASN PLEC MGA GOLGA3 MYBL2 | 1.73e-09 | 418 | 165 | 15 | 34709266 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM5B LIMA1 STIM2 MYCBP2 MAP4 RIMKLA PPFIA1 CEP192 WNK1 ENKD1 MADD KIAA1671 CCDC88C FAM171A2 SYNJ2 CEP112 NAV2 SH3BP5L MTCL1 PLEC | 5.72e-09 | 861 | 165 | 20 | 36931259 |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 2.49e-08 | 19 | 165 | 5 | 28067227 | |
| Pubmed | DGCR2 GGA2 SZT2 VPS50 ZNF507 FBRSL1 KIAA1549 PCDHA3 CELSR3 NUAK1 SYNJ2 ARHGEF7 NAV2 LRP4 OGA | 3.98e-08 | 529 | 165 | 15 | 14621295 | |
| Pubmed | RIPOR2 ARHGEF11 WNK1 PIAS1 ENKD1 MADD SYNJ2 ARHGEF7 NAV2 SH3BP5L PLEC HERC2 MBD5 MGA | 9.49e-08 | 486 | 165 | 14 | 20936779 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 1.00e-07 | 10 | 165 | 4 | 24207026 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LIMA1 PPAN MYCBP2 MAP4 EML4 ZNF507 ZNF318 HUWE1 FASN RRP12 SNAI1 PLEC SNAPC4 MAPK8 OGA KDM6A MYBL2 | 1.89e-07 | 774 | 165 | 17 | 15302935 |
| Pubmed | 2.15e-07 | 130 | 165 | 8 | 12421765 | ||
| Pubmed | 2.35e-07 | 12 | 165 | 4 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 4.71e-07 | 14 | 165 | 4 | 11793228 | |
| Pubmed | ZSWIM8 KDM5B MYCBP2 UBR4 HLCS HUWE1 PIAS1 RYR3 MADD CREBZF ZNF18 RNF220 CELSR3 RETREG1 LRP4 PLEC HERC2 CABIN1 KDM6A PREX1 GOLGA3 | 8.56e-07 | 1285 | 165 | 21 | 35914814 | |
| Pubmed | LIMA1 PPAN ERCC4 UBR4 ZNF507 FBRSL1 ZNF318 CEP192 TRIM24 PIAS1 HIRA MRPL4 KIAA1671 GLI3 RRP12 PITX1 HERC2 CABIN1 MGA KDM6A MYBL2 FTSJ3 | 1.23e-06 | 1429 | 165 | 22 | 35140242 | |
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 1.42e-06 | 18 | 165 | 4 | 17097888 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | FOXN2 ABCA1 COL12A1 TNC ZNF507 RB1CC1 WNK1 OGDHL PLEC CABIN1 MGA | 1.45e-06 | 363 | 165 | 11 | 14691545 |
| Pubmed | KDM5B FOXN2 ZNF507 DUX4L2 ZNF318 TRIM24 PIAS1 ZNF18 LMX1A GLI3 SNAI1 SNAPC4 MGA KDM6A TCF7L1 MYBL2 | 1.70e-06 | 808 | 165 | 16 | 20412781 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | 2.74e-06 | 21 | 165 | 4 | 8622927 | |
| Pubmed | 2.74e-06 | 21 | 165 | 4 | 14583620 | ||
| Pubmed | 2.74e-06 | 21 | 165 | 4 | 24923560 | ||
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | 2.74e-06 | 21 | 165 | 4 | 11468161 | |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | 2.74e-06 | 21 | 165 | 4 | 8756639 | |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | 2.74e-06 | 21 | 165 | 4 | 12447969 | |
| Pubmed | 2.74e-06 | 21 | 165 | 4 | 18980247 | ||
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 2.75e-06 | 182 | 165 | 8 | 31067453 | |
| Pubmed | 3.34e-06 | 22 | 165 | 4 | 9154835 | ||
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 4.03e-06 | 50 | 165 | 5 | 31806660 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | 4.82e-06 | 24 | 165 | 4 | 8995226 | |
| Pubmed | STIM2 GGA2 PPFIA1 CNKSR2 ZNF318 CEP192 HUWE1 TASOR2 KIAA1671 RABL6 FAM171A2 GLI3 PKLR MGA GOLGA3 | 4.94e-06 | 777 | 165 | 15 | 35844135 | |
| Pubmed | 5.57e-06 | 339 | 165 | 10 | 30415952 | ||
| Pubmed | 5.72e-06 | 25 | 165 | 4 | 21115691 | ||
| Pubmed | 5.77e-06 | 8 | 165 | 3 | 9023306 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 6.38e-06 | 95 | 165 | 6 | 29643511 | |
| Pubmed | 6.73e-06 | 26 | 165 | 4 | 35816173 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 CACNA1S UBR4 CNKSR2 WNK1 PIAS1 TASOR2 KIAA1671 AP5B1 PLEC MGA | 7.28e-06 | 430 | 165 | 11 | 35044719 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | LIMA1 MYCBP2 PPP1R9A ZNF318 KIAA1671 PITX1 CDC73 PLEC LRRFIP2 FTSJ3 | 9.64e-06 | 361 | 165 | 10 | 30344098 |
| Pubmed | TTF2 LIMA1 PPFIA1 PPP1R9A KIAA1549 CEP192 WNK1 KIAA1671 CCDC88C TBC1D22A MTCL1 | 1.02e-05 | 446 | 165 | 11 | 24255178 | |
| Pubmed | 1.06e-05 | 29 | 165 | 4 | 32527007 | ||
| Pubmed | 1.06e-05 | 29 | 165 | 4 | 23077214 | ||
| Pubmed | MYCBP2 PPFIA1 DUSP2 PPP1R9A KIAA1549 CEP192 HUWE1 RB1CC1 PPEF2 MADD KIAA1671 FAM171A2 RRP12 HERC2 MAPK8 KDM6A FTSJ3 | 1.13e-05 | 1049 | 165 | 17 | 27880917 | |
| Pubmed | 1.39e-05 | 31 | 165 | 4 | 19796621 | ||
| Pubmed | LIMA1 MAP4 UBR4 HUWE1 RB1CC1 TASOR2 CCDC88C FASN CDC73 PLEC MGA GOLGA3 | 1.40e-05 | 551 | 165 | 12 | 34728620 | |
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 29163030 | ||
| Pubmed | 1.80e-05 | 33 | 165 | 4 | 10704284 | ||
| Pubmed | 1.80e-05 | 33 | 165 | 4 | 20228807 | ||
| Pubmed | 2.03e-05 | 34 | 165 | 4 | 20403174 | ||
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | 2.03e-05 | 34 | 165 | 4 | 14699124 | |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | 2.03e-05 | 34 | 165 | 4 | 15780755 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | 2.03e-05 | 34 | 165 | 4 | 19188362 | |
| Pubmed | 2.03e-05 | 34 | 165 | 4 | 11941478 | ||
| Pubmed | 2.03e-05 | 34 | 165 | 4 | 17109758 | ||
| Pubmed | 2.03e-05 | 34 | 165 | 4 | 20388806 | ||
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | 2.03e-05 | 34 | 165 | 4 | 20715989 | |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | 2.03e-05 | 34 | 165 | 4 | 9806828 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | 2.03e-05 | 34 | 165 | 4 | 20368735 | |
| Pubmed | 2.03e-05 | 34 | 165 | 4 | 10936051 | ||
| Pubmed | 2.03e-05 | 34 | 165 | 4 | 21448158 | ||
| Pubmed | ANKRD31 ABCA1 USP17L4 USP17L1 CNKSR2 ZXDA ZXDB PKD2 NAV2 USP17L3 LONRF3 KDM6A USP17L8 | 2.18e-05 | 674 | 165 | 13 | 37196079 | |
| Pubmed | Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. | 2.24e-05 | 12 | 165 | 3 | 12748276 | |
| Pubmed | Secreted TARSH regulates olfactory mitral cell dendritic complexity. | 2.24e-05 | 12 | 165 | 3 | 19302145 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16192272 | ||
| Pubmed | HIRA contributes to zygote formation in mice and is implicated in human 1PN zygote phenotype. | 2.24e-05 | 2 | 165 | 2 | 33835048 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 17360660 | ||
| Pubmed | A mouse model for tracking nigrostriatal dopamine neuron axon growth. | 2.24e-05 | 2 | 165 | 2 | 18327786 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15185077 | ||
| Pubmed | Pitx1 determines characteristic hindlimb morphologies in cartilage micromass culture. | 2.24e-05 | 2 | 165 | 2 | 28746404 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 8268913 | ||
| Pubmed | Cloning and mapping of murine Dgcr2 and its homology to the Sez-12 seizure-related protein. | 2.24e-05 | 2 | 165 | 2 | 9107688 | |
| Pubmed | Palmitoylation of ATP-binding cassette transporter A1 is essential for its trafficking and function. | 2.24e-05 | 2 | 165 | 2 | 19556522 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | 2.28e-05 | 35 | 165 | 4 | 16611142 | |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | 2.28e-05 | 35 | 165 | 4 | 21239494 | |
| Pubmed | 2.56e-05 | 36 | 165 | 4 | 20147298 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZSWIM8 VPS50 ZNF507 FBRSL1 ZNF318 CEP192 HUWE1 WNK1 PIAS1 KIAA1671 SH3BP5L MYBL2 | 2.64e-05 | 588 | 165 | 12 | 38580884 |
| Pubmed | DGCR2 TTF2 STIM2 MYCBP2 UBR4 HUWE1 PIAS1 CREBZF PLEC HERC2 MGA KDM6A | 2.78e-05 | 591 | 165 | 12 | 15231748 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | 2.86e-05 | 37 | 165 | 4 | 20228808 | |
| Pubmed | 2.86e-05 | 37 | 165 | 4 | 10337614 | ||
| Pubmed | 3.01e-05 | 253 | 165 | 8 | 29911972 | ||
| Pubmed | 3.18e-05 | 38 | 165 | 4 | 29321139 | ||
| Pubmed | 3.18e-05 | 76 | 165 | 5 | 27542412 | ||
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 3.67e-05 | 14 | 165 | 3 | 27626314 | |
| Pubmed | 3.67e-05 | 14 | 165 | 3 | 33195246 | ||
| Pubmed | 4.52e-05 | 347 | 165 | 9 | 17114649 | ||
| Pubmed | 4.58e-05 | 15 | 165 | 3 | 25762221 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 4.73e-05 | 349 | 165 | 9 | 25665578 | |
| Pubmed | 5.22e-05 | 43 | 165 | 4 | 12376548 | ||
| Pubmed | Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. | 5.72e-05 | 44 | 165 | 4 | 27534441 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TTF2 FOXN2 CMTR1 UBR4 HUWE1 CBFA2T3 TRIM24 CASZ1 HIRA FASN CABIN1 MGA LRRFIP2 MYBL2 | 6.39e-05 | 857 | 165 | 14 | 25609649 |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 30082790 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 9922405 | ||
| Pubmed | A splice form of polycystin-2, lacking exon 7, does not interact with polycystin-1. | 6.69e-05 | 3 | 165 | 2 | 16192288 | |
| Pubmed | DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? | 6.69e-05 | 3 | 165 | 2 | 23206257 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 38514847 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 24172139 | ||
| Interaction | TOP3B interactions | DGCR2 LIMA1 MYCBP2 SZT2 SPEG PPP1R9A UBR4 NTSR1 OBSCN FBRSL1 CEP192 HUWE1 ARHGEF11 WNK1 ZDHHC8 CASZ1 MADD HIRA RABL6 CCDC88C FASN CELSR3 NUAK1 RRP12 PITX1 NAV2 LRP4 OGDHL ZFYVE26 SH3BP5L PLEC HERC2 SNAPC4 MBD5 CABIN1 OGA ANKRD33B PREX1 TTC38 MYBL2 TJP3 | 4.44e-13 | 1470 | 158 | 41 | int:TOP3B |
| Interaction | YWHAZ interactions | KDM5B LIMA1 STIM2 RIPOR2 MYCBP2 SPEG PPFIA1 CNKSR2 CEP192 HUWE1 RB1CC1 WNK1 PIAS1 MADD KIAA1671 CCDC88C ADRA2A FAM171A2 ARHGEF7 CEP112 NAV2 SH3BP5L MAP3K15 SNAI1 CDC73 PLEC HERC2 MAPK8 GOLGA3 | 3.86e-07 | 1319 | 158 | 29 | int:YWHAZ |
| Interaction | YWHAH interactions | KDM5B LIMA1 STIM2 MYCBP2 RIMKLA SPEG PPFIA1 CEP192 HUWE1 RB1CC1 WNK1 ENKD1 MADD KIAA1671 CCDC88C FAM171A2 NUAK1 SYNJ2 ARHGEF7 CEP112 NAV2 SH3BP5L MAP3K15 MTCL1 PLEC | 1.58e-06 | 1102 | 158 | 25 | int:YWHAH |
| Interaction | YWHAG interactions | KDM5B LIMA1 STIM2 RIPOR2 MYCBP2 RIMKLA SPEG PPFIA1 CEP192 HUWE1 RB1CC1 PPEF2 WNK1 PIAS1 ENKD1 KIAA1671 CCDC88C FAM171A2 NUAK1 SYNJ2 ARHGEF7 CEP112 NAV2 SH3BP5L MTCL1 | 1.39e-05 | 1248 | 158 | 25 | int:YWHAG |
| Interaction | YWHAB interactions | KDM5B LIMA1 STIM2 MYCBP2 SPEG PPFIA1 CEP192 RB1CC1 WNK1 KIAA1671 CCDC88C FAM171A2 NUAK1 SYNJ2 ARHGEF7 TBC1D22A CEP112 NAV2 SH3BP5L MTCL1 CDC73 MAPK8 | 1.44e-05 | 1014 | 158 | 22 | int:YWHAB |
| Interaction | PHF21A interactions | MYCBP2 PPFIA1 UBR4 VPS50 ZNF507 ZNF318 HUWE1 RB1CC1 KIAA1671 PLEC MGA GOLGA3 | 1.74e-05 | 343 | 158 | 12 | int:PHF21A |
| Interaction | YWHAQ interactions | CACNA1S KDM5B LIMA1 MYCBP2 MAP4 SPEG PPFIA1 CEP192 WNK1 ENKD1 KIAA1671 CCDC88C FASN FAM171A2 SYNJ2 CEP112 NAV2 SH3BP5L SNAI1 CDC73 PLEC CABIN1 UNC79 | 2.10e-05 | 1118 | 158 | 23 | int:YWHAQ |
| Interaction | MYCBP2 interactions | LIMA1 PRR36 MYCBP2 MAP4 PPP1R9A UBR4 PCDHA3 HUWE1 ARHGEF11 HERC2 UNC79 LRRFIP2 | 2.44e-05 | 355 | 158 | 12 | int:MYCBP2 |
| Interaction | AURKB interactions | ZSWIM8 LIMA1 PPAN PPFIA1 UBR4 CEP192 HUWE1 WNK1 OGDH MRPL4 FASN RRP12 CDC73 PLEC HERC2 SNAPC4 MBD5 FTSJ3 | 3.03e-05 | 761 | 158 | 18 | int:AURKB |
| Interaction | RCOR1 interactions | KDM5B MYCBP2 EML4 PPFIA1 UBR4 VPS50 ZNF318 HUWE1 RB1CC1 FASN SNAI1 PLEC MGA GOLGA3 | 3.60e-05 | 494 | 158 | 14 | int:RCOR1 |
| Interaction | GDF10 interactions | 3.84e-05 | 9 | 158 | 3 | int:GDF10 | |
| Interaction | HDAC2 interactions | KDM5B LIMA1 MYCBP2 MAP4 EML4 DUX4 ZNF318 HUWE1 CBFA2T3 WNK1 CASZ1 ARHGEF7 CDADC1 SNAI1 CDC73 HERC2 CABIN1 KDM6A MYBL2 | 4.93e-05 | 865 | 158 | 19 | int:HDAC2 |
| Cytoband | 4q35.2 | 4.40e-08 | 27 | 166 | 5 | 4q35.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q35 | 4.58e-06 | 117 | 166 | 6 | chr4q35 | |
| Cytoband | 15q14-q15 | 1.29e-04 | 5 | 166 | 2 | 15q14-q15 | |
| Cytoband | Xp22.12 | 3.59e-04 | 8 | 166 | 2 | Xp22.12 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 9.97e-07 | 92 | 104 | 7 | 521 | |
| GeneFamily | SNAP complex | 3.24e-04 | 5 | 104 | 2 | 952 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.66e-04 | 66 | 104 | 4 | 722 | |
| GeneFamily | Sterile alpha motif domain containing | 1.66e-03 | 88 | 104 | 4 | 760 | |
| GeneFamily | PDZ domain containing | 1.85e-03 | 152 | 104 | 5 | 1220 | |
| Coexpression | GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN | 4.24e-06 | 196 | 164 | 9 | M5791 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_1H_BMDC_DN | 4.80e-06 | 199 | 164 | 9 | M3800 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | KDM5B ERCC4 CCNDBP1 SPEG VPS50 KIAA1549 GRB14 CEP192 EFCAB14 RETREG3 HIRA MIGA2 TBC1D22A RETREG1 NAV2 LRP4 PLEC CABIN1 KDM6A TCF7L1 | 1.96e-05 | 1102 | 164 | 20 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | KDM5B ERCC4 CCNDBP1 SPEG VPS50 KIAA1549 GRB14 CEP192 EFCAB14 RETREG3 HIRA MIGA2 TBC1D22A RETREG1 NAV2 LRP4 PLEC CABIN1 KDM6A TCF7L1 | 2.59e-05 | 1124 | 164 | 20 | MM1070 |
| ToppCell | LA|World / Chamber and Cluster_Paper | 3.71e-08 | 193 | 161 | 9 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.11e-07 | 192 | 161 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.31e-07 | 193 | 161 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Kidney-nan-3m-Hematologic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 181 | 161 | 7 | 58d7e76dfaa818aeaef7f129c4472bf5b6563218 | |
| ToppCell | droplet-Kidney-nan-3m-Hematologic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 181 | 161 | 7 | 5d76e99bf2b5b337041efd3cd33bebbb0637b64e | |
| ToppCell | droplet-Kidney-nan-3m-Hematologic-leukocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 181 | 161 | 7 | 970fc90e27236ee30190f1a02f418a378919c60b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.07e-06 | 185 | 161 | 7 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.07e-06 | 185 | 161 | 7 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 5.44e-06 | 187 | 161 | 7 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.64e-06 | 188 | 161 | 7 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.64e-06 | 188 | 161 | 7 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.84e-06 | 189 | 161 | 7 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-06 | 190 | 161 | 7 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.04e-06 | 190 | 161 | 7 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.92e-06 | 194 | 161 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 195 | 161 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 195 | 161 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.40e-06 | 196 | 161 | 7 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.91e-06 | 198 | 161 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.17e-06 | 199 | 161 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.45e-06 | 200 | 161 | 7 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.45e-06 | 200 | 161 | 7 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | control-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.59e-05 | 147 | 161 | 6 | 68258498202c7f580f72c46dd645071835098455 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.00e-05 | 153 | 161 | 6 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-05 | 163 | 161 | 6 | aa5ea367f787c1543afb7eb80a801432e1c44011 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.16e-05 | 166 | 161 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.16e-05 | 166 | 161 | 6 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-05 | 168 | 161 | 6 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 169 | 161 | 6 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 3.86e-05 | 172 | 161 | 6 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-05 | 177 | 161 | 6 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 178 | 161 | 6 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.82e-05 | 179 | 161 | 6 | db76edd368eeca05a2a5d407c3eb2f535ade0ce3 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 4.97e-05 | 180 | 161 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 182 | 161 | 6 | d0d18dd5d8b2d21e42c3c4259f824c91f24a54bc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 182 | 161 | 6 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.29e-05 | 182 | 161 | 6 | d486b0213bd3cf20965cb4e38e95981c4aaff259 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.29e-05 | 182 | 161 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 5.45e-05 | 183 | 161 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.45e-05 | 183 | 161 | 6 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 184 | 161 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 184 | 161 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 184 | 161 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.79e-05 | 185 | 161 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.79e-05 | 185 | 161 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.79e-05 | 185 | 161 | 6 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | proximal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.96e-05 | 186 | 161 | 6 | c920dffd24f051b54d8b48f801fffc928d99e135 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.96e-05 | 186 | 161 | 6 | d740aca5dc4240851ba7bc5988c0970d785ad0c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 186 | 161 | 6 | d4e327cc1d7b618654ffe0ff6475fe8e8cc5cb01 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.96e-05 | 186 | 161 | 6 | 4ca7f6c043874a0c536f75af5ca24c7c66725e54 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-05 | 186 | 161 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.14e-05 | 187 | 161 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.14e-05 | 187 | 161 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-05 | 187 | 161 | 6 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.33e-05 | 188 | 161 | 6 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.33e-05 | 188 | 161 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 6.33e-05 | 188 | 161 | 6 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.33e-05 | 188 | 161 | 6 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.33e-05 | 188 | 161 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.52e-05 | 189 | 161 | 6 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 189 | 161 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 189 | 161 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 190 | 161 | 6 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.91e-05 | 191 | 161 | 6 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.91e-05 | 191 | 161 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.91e-05 | 191 | 161 | 6 | 48cffb55c71bb8b34e926fc461fcd345ce43ea00 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.91e-05 | 191 | 161 | 6 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 192 | 161 | 6 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.11e-05 | 192 | 161 | 6 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 7.11e-05 | 192 | 161 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.31e-05 | 193 | 161 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.31e-05 | 193 | 161 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 7.31e-05 | 193 | 161 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.31e-05 | 193 | 161 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.53e-05 | 194 | 161 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class | 7.74e-05 | 195 | 161 | 6 | b95a631d54c6cf85e48e1e638703206aaaebc073 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.74e-05 | 195 | 161 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.74e-05 | 195 | 161 | 6 | 4d7ca21f14730e1b6d0473bc1a11aa626db948f3 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 7.74e-05 | 195 | 161 | 6 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-epithelial_cell-epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.74e-05 | 195 | 161 | 6 | 8727554ef047ca7f1d4b888a8468f148c64a6918 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.74e-05 | 195 | 161 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-epithelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 195 | 161 | 6 | 9f0ee826d4f0997aee8d63284ed24549bbdf6a28 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.74e-05 | 195 | 161 | 6 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-B_(Artery)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.96e-05 | 196 | 161 | 6 | f540cf17b4405a6dd38d2b6123e6541d0aac889e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.96e-05 | 196 | 161 | 6 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 7.96e-05 | 196 | 161 | 6 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 197 | 161 | 6 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.42e-05 | 198 | 161 | 6 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | (2)_Fibroblasts-(23)_Fibro-4|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.42e-05 | 198 | 161 | 6 | e0ef49ec0f87cc87b45efa297b9ff6c35b7a2ba9 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.42e-05 | 198 | 161 | 6 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 198 | 161 | 6 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.42e-05 | 198 | 161 | 6 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 199 | 161 | 6 | 26bb93347e6722abd174dfa62cab692ce2b7eb23 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-05 | 199 | 161 | 6 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 8.66e-05 | 199 | 161 | 6 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 8.90e-05 | 200 | 161 | 6 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 133 | 161 | 5 | f6e9a1301a3379847b215303a9b0c028841e2cc0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 133 | 161 | 5 | 292ecfcadbaf15e0d34a3ab9bf511ab1065888bd | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.72e-04 | 143 | 161 | 5 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-04 | 147 | 161 | 5 | c8e5bdc3538089acd35a4b41390afaec0ac6d1aa | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | DGCR2 MAP4 PPFIA1 CBFA2T3 WNK1 SYNJ2 PITX1 SNAPC2 PLEC SNAPC4 | 7.53e-07 | 182 | 162 | 10 | 1663_DN |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | ERCC4 DUSP2 TOP6BL CALHM2 CCDC88C SYNJ2 ZFYVE26 SNAPC4 CABIN1 TJP3 | 1.29e-06 | 193 | 162 | 10 | 5588_DN |
| Drug | Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; PC3; HT_HG-U133A | ABCA1 NTSR1 HLCS ARHGEF11 PTGIS CALHM2 CCDC88C TBC1D22A RRP12 PITX1 | 1.62e-06 | 198 | 162 | 10 | 7302_UP |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 1.70e-06 | 199 | 162 | 10 | 1660_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 3.89e-06 | 171 | 162 | 9 | 7535_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 9.16e-06 | 190 | 162 | 9 | 4274_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.18e-05 | 196 | 162 | 9 | 1708_DN | |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; HL60; HT_HG-U133A | 1.18e-05 | 196 | 162 | 9 | 2390_DN | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.22e-05 | 197 | 162 | 9 | 5045_UP | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.22e-05 | 197 | 162 | 9 | 6621_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | VPS50 EFCAB14 TOP6BL CREBZF SYNJ2 EHHADH TBC1D22A SNAPC2 LONRF3 | 1.22e-05 | 197 | 162 | 9 | 6026_DN |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A | 1.22e-05 | 197 | 162 | 9 | 5735_DN | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.27e-05 | 198 | 162 | 9 | 4977_UP | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.27e-05 | 198 | 162 | 9 | 5944_DN | |
| Drug | Rolitetracycline [751-97-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 5.56e-05 | 185 | 162 | 8 | 3369_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 5.56e-05 | 185 | 162 | 8 | 4445_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.46e-05 | 189 | 162 | 8 | 1006_DN | |
| Drug | Phenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 6.46e-05 | 189 | 162 | 8 | 2832_UP | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 6.71e-05 | 190 | 162 | 8 | 7070_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 6.96e-05 | 191 | 162 | 8 | 4269_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 6.96e-05 | 191 | 162 | 8 | 4647_DN | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 7.22e-05 | 192 | 162 | 8 | 3164_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 7.22e-05 | 192 | 162 | 8 | 4743_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.22e-05 | 192 | 162 | 8 | 993_DN | |
| Drug | IAA-94 | 7.39e-05 | 61 | 162 | 5 | CID000003667 | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 7.48e-05 | 193 | 162 | 8 | 5764_DN | |
| Drug | Harmine hydrochloride [343-27-1]; Up 200; 16uM; PC3; HT_HG-U133A | 7.76e-05 | 194 | 162 | 8 | 5855_UP | |
| Drug | Gly-His-Lys acetate salt; Down 200; 1uM; MCF7; HT_HG-U133A | 7.76e-05 | 194 | 162 | 8 | 6575_DN | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 8.04e-05 | 195 | 162 | 8 | 4748_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 8.04e-05 | 195 | 162 | 8 | 5444_UP | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; HL60; HG-U133A | 8.04e-05 | 195 | 162 | 8 | 2004_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; PC3; HT_HG-U133A | 8.04e-05 | 195 | 162 | 8 | 7318_UP | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 8.04e-05 | 195 | 162 | 8 | 5329_DN | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 8.04e-05 | 195 | 162 | 8 | 1823_DN | |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | 8.04e-05 | 195 | 162 | 8 | 5744_DN | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HT_HG-U133A | 8.04e-05 | 195 | 162 | 8 | 4063_UP | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; HL60; HG-U133A | 8.33e-05 | 196 | 162 | 8 | 1987_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 7356_DN | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Up 200; 13uM; HL60; HG-U133A | 8.33e-05 | 196 | 162 | 8 | 1604_UP | |
| Drug | Benzthiazide [91-33-8]; Up 200; 9.2uM; PC3; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 6607_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A_EA | 8.33e-05 | 196 | 162 | 8 | 1002_DN | |
| Drug | Nomegestrol acetate [58652-20-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 5461_UP | |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 5505_DN | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 4826_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 7408_UP | |
| Drug | CNS 1145 | 8.60e-05 | 33 | 162 | 4 | CID000190902 | |
| Drug | IHC-64 | 8.60e-05 | 33 | 162 | 4 | CID000162753 | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; HL60; HG-U133A | 8.64e-05 | 197 | 162 | 8 | 1975_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 3629_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 3364_DN | |
| Drug | Demecarium bromide [56-94-0]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 2773_UP | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; HL60; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 3056_DN | |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 7213_DN | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 4679_UP | |
| Drug | (+/-)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 8.64e-05 | 197 | 162 | 8 | 161_DN | |
| Drug | Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 5616_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 1635_DN | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 7171_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 5746_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 7323_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 3842_UP | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 2898_DN | |
| Drug | Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 5434_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; HL60; HG-U133A | 8.95e-05 | 198 | 162 | 8 | 1997_DN | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 5457_UP | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; HL60; HG-U133A | 8.95e-05 | 198 | 162 | 8 | 1435_UP | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; HL60; HG-U133A | 8.95e-05 | 198 | 162 | 8 | 1976_DN | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 2847_DN | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 7334_DN | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 6596_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 1677_DN | |
| Drug | Propantheline bromide [50-34-0]; Down 200; 9uM; HL60; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 3013_DN | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | 9.26e-05 | 199 | 162 | 8 | 5048_UP | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 9.26e-05 | 199 | 162 | 8 | 3860_DN | |
| Drug | rapamycin; Down 200; 0.1uM; ssMCF7; HG-U133A | 9.26e-05 | 199 | 162 | 8 | 402_DN | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A | 9.59e-05 | 200 | 162 | 8 | 2077_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 9.59e-05 | 200 | 162 | 8 | 6246_UP | |
| Drug | eg D | 9.70e-05 | 34 | 162 | 4 | CID000029544 | |
| Drug | gallopamil | 1.16e-04 | 67 | 162 | 5 | CID000001234 | |
| Drug | AC1L1KS5 | 1.46e-04 | 334 | 162 | 10 | CID000005631 | |
| Drug | CAS 298-57-7 | 1.74e-04 | 73 | 162 | 5 | CID000002761 | |
| Drug | CAS 22457-89-2 | 1.85e-04 | 16 | 162 | 3 | CID000002320 | |
| Drug | DB08219 | 2.69e-04 | 44 | 162 | 4 | CID011840966 | |
| Drug | bepridil | 2.88e-04 | 126 | 162 | 6 | CID000002351 | |
| Drug | Piperlongumine [20069-09-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.92e-04 | 178 | 162 | 7 | 2757_DN | |
| Drug | AC1N3SS3 | 2.93e-04 | 45 | 162 | 4 | CID000000592 | |
| Drug | ammonium lactate | 2.99e-04 | 4 | 162 | 2 | CID000062358 | |
| Drug | McN-5691 | 2.99e-04 | 4 | 162 | 2 | CID000127269 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.13e-04 | 180 | 162 | 7 | 4541_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.34e-04 | 182 | 162 | 7 | 3630_DN | |
| Drug | protocol C | 3.69e-04 | 20 | 162 | 3 | CID000015824 | |
| Drug | HepI | 3.69e-04 | 20 | 162 | 3 | CID003036968 | |
| Drug | 5224221; Down 200; 12uM; MCF7; HT_HG-U133A_EA | 3.81e-04 | 186 | 162 | 7 | 839_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 3.81e-04 | 186 | 162 | 7 | 4463_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.94e-04 | 187 | 162 | 7 | 1242_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 4.20e-04 | 189 | 162 | 7 | 3262_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A | 4.33e-04 | 190 | 162 | 7 | 4582_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.33e-04 | 190 | 162 | 7 | 3966_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 4.33e-04 | 190 | 162 | 7 | 5237_UP | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A | 4.33e-04 | 190 | 162 | 7 | 6718_DN | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.09e-05 | 195 | 158 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | oxoglutarate dehydrogenase deficiency (implicated_via_orthology) | 2.85e-05 | 2 | 158 | 2 | DOID:0081326 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | UBR4 OBSCN HLCS ZNF318 RB1CC1 WNK1 MFAP5 FASN SYNJ2 P3H2 FAM217B ZFYVE26 SNAI1 HERC2 LONRF3 NMBR TCF7L1 | 6.75e-05 | 1074 | 158 | 17 | C0006142 |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | 1.08e-04 | 46 | 158 | 4 | DOID:5426 (implicated_via_orthology) | |
| Disease | emphysema imaging measurement | 1.40e-04 | 146 | 158 | 6 | EFO_0007626 | |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 1.70e-04 | 4 | 158 | 2 | C2752089 | |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 1.70e-04 | 4 | 158 | 2 | cv:C5574675 | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 1.70e-04 | 4 | 158 | 2 | cv:C2752089 | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 1.70e-04 | 4 | 158 | 2 | 201300 | |
| Disease | Episodic Ataxia | 1.70e-04 | 4 | 158 | 2 | C1720189 | |
| Disease | colorectal adenoma (is_implicated_in) | 2.82e-04 | 5 | 158 | 2 | DOID:0050860 (is_implicated_in) | |
| Disease | brain disease (implicated_via_orthology) | 4.21e-04 | 6 | 158 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 5.22e-04 | 69 | 158 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | right ventricular ejection fraction measurement | 5.50e-04 | 30 | 158 | 3 | EFO_0021816 | |
| Disease | Polysyndactyly | 5.88e-04 | 7 | 158 | 2 | C0265553 | |
| Disease | pantothenate measurement | 7.81e-04 | 8 | 158 | 2 | EFO_0021034 | |
| Disease | central serous retinopathy | 7.81e-04 | 8 | 158 | 2 | EFO_0009784 | |
| Disease | glucose measurement | 1.06e-03 | 380 | 158 | 8 | EFO_0004468 | |
| Disease | osteoarthritis, hip | 1.53e-03 | 92 | 158 | 4 | EFO_1000786 | |
| Disease | Myoinositol measurement | 1.82e-03 | 12 | 158 | 2 | EFO_0021652 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.82e-03 | 12 | 158 | 2 | C0023485 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 2.14e-03 | 13 | 158 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 2.14e-03 | 13 | 158 | 2 | C0270914 | |
| Disease | cortical thickness | RIPOR2 COL12A1 MYCBP2 ZNF318 NUAK1 LMX1A TBC1D22A CEP112 GLI3 NAV2 LRP4 MTCL1 PLEC NEUROG2 | 2.72e-03 | 1113 | 158 | 14 | EFO_0004840 |
| Disease | monoclonal gammopathy | 2.90e-03 | 53 | 158 | 3 | EFO_0000203 | |
| Disease | Schizophrenia | DGCR2 ABCA1 NTSR1 RB1CC1 ARHGEF11 SLC30A3 ZDHHC8 CHRNA3 ADRA2A LMX1A PITX3 MAPK8 | 2.94e-03 | 883 | 158 | 12 | C0036341 |
| Disease | interleukin-6 measurement | 3.14e-03 | 112 | 158 | 4 | EFO_0004810 | |
| Disease | DiGeorge Syndrome | 3.25e-03 | 16 | 158 | 2 | C0012236 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 3.25e-03 | 16 | 158 | 2 | C0795907 | |
| Disease | Shprintzen syndrome | 3.25e-03 | 16 | 158 | 2 | C0220704 | |
| Disease | Polydactyly | 3.67e-03 | 117 | 158 | 4 | C0152427 | |
| Disease | atrial fibrillation | 3.96e-03 | 371 | 158 | 7 | EFO_0000275 | |
| Disease | serum homoarginine measurement | 5.08e-03 | 20 | 158 | 2 | EFO_0005421 | |
| Disease | Adenocarcinoma of lung (disorder) | 5.14e-03 | 206 | 158 | 5 | C0152013 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 5.16e-03 | 65 | 158 | 3 | DOID:0080208 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DTVSDRLASEELPST | 496 | Q6ZT62 | |
| SDDDSVLEATSSRDP | 176 | Q9HCM7 | |
| VLEATSSRDPLSDSS | 181 | Q9HCM7 | |
| DLLTSDRALDTTAPR | 41 | Q9H0I2 | |
| EASTSASIDRSAPLE | 101 | Q6P1J9 | |
| ESVDAVLSLSALSPE | 426 | P32297 | |
| SSSSEAKLSPREEEE | 41 | Q7L8J4 | |
| RTDSEESLPEAAAEA | 1716 | Q86V15 | |
| SDIDPESRETDLLSG | 1296 | O95477 | |
| GSFPEDLLESDSSRS | 591 | O15085 | |
| PELDRNLAEDASSTE | 1301 | O15085 | |
| PVSLDDSDIEARLNS | 196 | Q8N8E3 | |
| SLSRLEPSDLSEDSD | 761 | Q14155 | |
| PEISLLTEASSSEDA | 156 | Q9BWV3 | |
| ASEEAASLEAPLSEE | 401 | P0CJ89 | |
| TIDPSTARDLDDALS | 381 | Q8IYB7 | |
| TSRPSDSDVSLEEDR | 56 | O00305 | |
| LLRTEPPDSDSESSS | 31 | O75071 | |
| EDFSSLPDTRSIASD | 41 | A6NCL7 | |
| DDRLDRSFLEDTTPA | 396 | Q3YEC7 | |
| LLSDPVETSAEARAA | 471 | Q6ZRI8 | |
| SEPELGEIRDSSAST | 351 | Q8IXN7 | |
| SDEQRLLPAASSDAE | 221 | Q9Y4B5 | |
| PADAEKDRLITTDSD | 1611 | Q9HCM3 | |
| TSAQRSSIDPLDIED | 616 | Q8N7Z5 | |
| QVSLDLDSLAESPES | 716 | Q8TDY2 | |
| MADTLESSLEDPLRS | 1 | Q9H867 | |
| SLVLDSPLDRESVSA | 406 | Q9Y5H8 | |
| ERDFLPASDGTTTEL | 26 | P28336 | |
| VSEEPSTSSDERASL | 71 | P10071 | |
| PNSLRLASDSDAESD | 811 | Q8WXG6 | |
| DDDLADLVFPSSATA | 146 | P27816 | |
| ASEEAASLEAPLSEE | 401 | Q9UBX2 | |
| SRFSESESRSPLEDE | 1666 | Q9BY89 | |
| SLAVRSTPAEDDSRD | 331 | Q9UHB6 | |
| ALAALTPLSSSADEE | 26 | Q9H2A3 | |
| LIASSFEDDSRVASP | 356 | Q8IWI9 | |
| NASERVLAAPSSELD | 41 | P30989 | |
| ALRALPEASLFDEST | 231 | O95714 | |
| SLPTSLERALSEDSA | 316 | P25090 | |
| LERALSEDSAPTNDT | 321 | P25090 | |
| ADADVPLDDLTFTIT | 1216 | Q5SZK8 | |
| EASPSLTAEEREALG | 36 | O15550 | |
| SSSLESVADETSPER | 136 | P50747 | |
| SFSSEDLIPSRDLAT | 1601 | Q9P219 | |
| LDEGSASVAELRPDS | 91 | Q05923 | |
| ALSEFVDPSSLTARE | 131 | Q9HA72 | |
| ASEEAASLEAPLSEE | 401 | P0CJ86 | |
| SALDVDEIASSTDRP | 411 | Q08426 | |
| ERELLSLVSPAASDS | 151 | Q8TE12 | |
| DADLDSFVPSDLITT | 141 | Q9ULD0 | |
| PTLASDTDSSLEAAA | 406 | P45983 | |
| EFLRLPSDSSSTVDL | 256 | Q9UGF5 | |
| PADLSTAIASRSVAD | 606 | P07202 | |
| EDSASDLSDSERIPI | 91 | Q9NTX9 | |
| SSASLVETEDPSLED | 441 | Q86UT5 | |
| DRDTLLSSVDLLSPS | 606 | Q13136 | |
| LDIDSEPVAARSTSI | 76 | P30613 | |
| SLRLRADDEDSLTSE | 276 | Q7L4E1 | |
| RPTLFRLASDTTDDD | 276 | Q9UJY4 | |
| SEETPSAAELQDLLD | 881 | Q9UGL1 | |
| PDASAAEVAATSLLD | 66 | Q2VPB7 | |
| SLLDDSIDPASIEAR | 351 | Q8IVL5 | |
| DASASSPIDSSELLL | 271 | O75081 | |
| EISLSPDTDDRLENT | 286 | Q08378 | |
| ITSLSPERAEDSDAL | 2831 | Q7Z6Z7 | |
| PERAEDSDALTAVSS | 2836 | Q7Z6Z7 | |
| TSSLIDPDTSLSELR | 331 | Q9Y608 | |
| VLADIAPSTDDLASL | 61 | Q13361 | |
| SASELRRDSLTSPED | 781 | A8MVW0 | |
| SLPEEAEASERSTEA | 6831 | Q5VST9 | |
| AADTISLDISEVDPA | 7291 | Q5VST9 | |
| NDSDTLELPDSSRAL | 56 | Q96RI0 | |
| QRDLSPTAEDAELSD | 431 | Q86WN1 | |
| DLDSSVPADIISSTD | 156 | Q02218 | |
| SRDDVSSFVDPALAL | 166 | Q5VT79 | |
| PDDRSQDSTAVALSD | 1371 | Q9Y6J0 | |
| ESESDDLIGSERTLP | 1731 | Q99715 | |
| LSSAALAAEDPIRAD | 811 | Q13698 | |
| SDEISPSVDDLALSI | 281 | O95273 | |
| DTATATTEDPELLAF | 256 | Q495W5 | |
| DRLLDLPAAASSEDI | 106 | P22466 | |
| ASEEAASLEAPLSEE | 401 | P0CJ90 | |
| DLEDSADSSSALLVP | 506 | P98153 | |
| SSSEEDALTEPRSSI | 71 | Q8NA82 | |
| SPSDAKSISSEDDLR | 1351 | Q9P267 | |
| PTTATDDALEDRKSD | 1051 | Q8TEP8 | |
| RPKATLVDSESADDE | 41 | P32314 | |
| DETSRALDVPSDITA | 116 | Q14449 | |
| EEESRISSSPTLLEN | 911 | Q9HC35 | |
| SLTSISSLPFEEDER | 746 | Q49AJ0 | |
| ELRPRDLLESSSDSD | 601 | P54198 | |
| SDLSLEEERSLSIPS | 2896 | Q9NYQ7 | |
| ASEEAASLEAPLSEE | 401 | P0CJ88 | |
| VSGSETSEALSRDPE | 111 | P49327 | |
| LSEAEARSPALSLSD | 6 | O75364 | |
| SEASSPDERTLTFAE | 1001 | Q8NG08 | |
| AELALSLSSTSDDEP | 21 | Q8N1G2 | |
| PSRSASEADSEAGEL | 416 | O14830 | |
| DESSALEDRGLASSP | 981 | Q6ZN16 | |
| SASESSDTELPEKER | 46 | P78337 | |
| LDSASLSDVDTVNPD | 1526 | Q5T011 | |
| STIDELDELFPSRDS | 741 | Q8IW52 | |
| ESPFERELSDSSGVL | 1841 | Q8WUY3 | |
| LSSLAEEAARATENP | 21 | Q9BYD3 | |
| DAPDNSSLELLADTS | 471 | Q8N6T0 | |
| SEEALSAVAPRDLEA | 1191 | O15056 | |
| EERESELSSNPAASA | 11 | O60502 | |
| TSDDLDRPSEEVFSR | 331 | Q9H6L5 | |
| DSTPVLDSVLSESLR | 336 | Q16647 | |
| SSLSEALDLIESDPD | 306 | P10244 | |
| AELLSPLDESRASIT | 1306 | Q9H6K5 | |
| LPSFEESEELEAASR | 456 | Q8IVL1 | |
| AEEASSLPLVSEESE | 1121 | Q8TCU6 | |
| SAADTFLSDLPRDDI | 441 | Q8IY81 | |
| DADDIPELLSSSSLF | 1931 | O75592 | |
| SPERSESSELLDSND | 481 | O60285 | |
| GLISDREASSSPEDR | 191 | Q5VTB9 | |
| LTADPDSEIATTSLR | 316 | O75925 | |
| SRVESTADDLGDALP | 66 | Q9H6W3 | |
| LDRAEPLLSSSLSSE | 866 | Q9Y4F9 | |
| LDPASSDFTRLSVLD | 741 | Q5JTH9 | |
| LDLEESSSSDHAERP | 306 | P08913 | |
| DPRDLTSAASAPSDL | 611 | Q8IUL8 | |
| SASLRVAPERLSDDS | 21 | Q96F83 | |
| TLPLEDSVFSDSAAI | 786 | Q8WXI2 | |
| LRSPSSDLDTDAEGD | 431 | Q86VR2 | |
| ESLIDLEVSADPTAT | 681 | Q96JG6 | |
| LEVSADPTATLTAAE | 686 | Q96JG6 | |
| SPLSSETRVDLCDDL | 41 | A6NCW0 | |
| ESPRVAELTSLSDED | 81 | O95863 | |
| SSAALDVELSDDSFP | 51 | P43308 | |
| DLSDAEIVSLFSDVP | 601 | P98169 | |
| STSEETVLRSDAPDS | 771 | O15164 | |
| SPLSSETRVDLCDDL | 41 | A6NCW7 | |
| SRVSLTDIPTEDEAL | 1946 | Q15772 | |
| PSSDSASAQRDLDEV | 51 | Q9HCS4 | |
| SPSDRDSASIVTIDA | 571 | Q6T4P5 | |
| SLEDSSRGDSPVTVD | 631 | Q9P246 | |
| IPSRTASLELGEDDD | 366 | Q9NQ55 | |
| PDLRASASLDTVSLS | 2391 | Q15413 | |
| DLDSPRDLTATEVQS | 1886 | P24821 | |
| LPSDLTRAAAGEEET | 31 | Q9NS37 | |
| SPLSSETRVDLCDDL | 41 | Q7RTZ2 | |
| RLLEDSDSEDEAAPS | 206 | Q9BW85 | |
| DEETSRALSAPRADA | 3301 | Q15149 | |
| LDEELPDLSVSRRSS | 246 | Q96GW9 | |
| SSRSFPRSLDDSEED | 801 | Q13563 | |
| DPSTLSSSALSEREA | 181 | Q8WUA7 | |
| STADPEAVLAEASSR | 341 | Q99726 | |
| RLSSEDSSLEPDLAE | 606 | A7E2V4 | |
| SDSSPLEDISDLASE | 286 | O95049 | |
| SDAEENLIPDSLLTS | 366 | Q8TCN5 | |
| ELLTTLRDASESPGE | 351 | Q5R3I4 | |
| LFSDVPDSTSAALLD | 606 | P98168 | |
| SPLSSETRVDLCDDL | 41 | P0C7I0 | |
| DDSIRSLDFVSEPSL | 386 | Q9ULC8 | |
| RSPISTDTSLDVLED | 441 | Q01118 | |
| SLESDSEADSLPSED | 36 | Q5SXM2 | |
| SEEDSDIDLALTISP | 1276 | Q5VWN6 | |
| SDAALQEELSSPETA | 26 | P17022 | |
| ATALAITADSETLPE | 826 | Q92889 | |
| SSDPEAAFLSRDVDD | 2011 | Q9H4A3 | |
| LSPEASEDDLNRLDS | 936 | Q5T4S7 | |
| SEASILSPEESDLAA | 296 | A0A286YF58 | |
| TSLVDSELSPSEDRE | 901 | Q6BDS2 | |
| SELSPSEDRELKSDA | 906 | Q6BDS2 | |
| SLDSSGPEDRISVDS | 1111 | Q6BDS2 | |
| DSLSEDLASATEPAN | 526 | Q68DK2 | |
| SPIALDVLSEAFEES | 1406 | Q68DK2 | |
| SDTSRDISPEKSELD | 1706 | Q5VUA4 | |
| RSPELSAAESAVVLD | 221 | Q13487 | |
| SALTLSELRDSEPSS | 956 | Q9UNY4 | |
| DSLEDSLLSSRPEFI | 891 | Q9P2D8 | |
| ASEEAASLEAPLSEE | 401 | P0CJ85 | |
| SFDTEDLSDDVIPLA | 756 | O75096 | |
| DLSDDVIPLADVRSA | 761 | O75096 | |
| SLPAEVSSDNLESAE | 11 | Q496Y0 | |
| DSLDSLSSRTEAVSP | 186 | Q9ULJ8 |